Enlivex ENLV
NASDAQ ENLV
$1.48 -0.02 (-1.33%)
As of: Aug 21, 2026 · 11:49 AM EDT

Enlivex (ENLV) EPS (Basic) (2014 - 2025)

Enlivex (ENLV) posted quarterly EPS (Basic) of -$1.61 for Q4 2025, up 52.76% year-over-year from -$1.05 in Q4 2024, and up 24.15% quarter-over-quarter from -$2.12 in Q3 2025.

Enlivex (ENLV) EPS (Basic) (2014 - 2025) Analysis & Trends

Enlivex's EPS (Basic) history runs 12 years deep, the most recent figure standing at -$1.61 for Q4 2025.

  • In Q4 2025, EPS (Basic) rose 52.76% year-over-year to -$1.61; the TTM figure through Dec 2025 stood at -$5.19 (up 59.38% YoY), while the FY2025 annual figure was $405.57, up 4897.63% from the prior year.
  • EPS (Basic) for Q4 2025 stood at -$1.61, up from -$2.12 in the prior quarter.
  • The five-year high for EPS (Basic) was $1.68 in Q2 2021, with the low at -$10.22 in Q4 2023.
  • The 5-year median for EPS (Basic) is -$3.57 (2024), against an average of -$3.97.
  • The sharpest annual moves came in 2021 and 2022: EPS (Basic) jumped 177.57% in 2021, then plunged 784.31% in 2022.
  • Enlivex's EPS (Basic) stood at -$6.9 in 2021, then dropped by 0.05% to -$6.9 in 2022, then sank by 48.1% to -$10.22 in 2023, then soared by 66.74% to -$3.4 in 2024, then surged by 52.76% to -$1.61 in 2025.
  • Business Quant data shows ENLV's EPS (Basic) at -$1.61 in Q4 2025, -$2.12 in Q3 2025, and -$2.29 in Q2 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EPS (Basic) (Qtr)
1 Vertex Pharmaceuticals 139.90 Bn 132.05 Bn 2.84 Bn 4.34
2 Regeneron Pharmaceuticals 86.70 Bn 78.71 Bn 3.93 Bn 12.62
3 Argenx Se 65.73 Bn 60.55 Bn 1.37 Bn 7.59
4 Moderna 58.33 Bn 53.19 Bn 52.00 Mn -1.96
5 BeOne Medicines 42.16 Bn 37.07 Bn 1.53 Bn 2.12
6 Alnylam Pharmaceuticals 31.72 Bn 28.42 Bn 992.69 Mn 1.23
7 BioNTech SE 28.27 Bn 9.88 Bn 668.28 Mn -0.72
8 Insmed 27.61 Bn 26.45 Bn 358.27 Mn -0.06
9 Royalty Pharma 27.25 Bn 26.41 Bn - 0.18
10 Enlivex 4.51 Mn -1.25 Mn - -1.92

Historic Data

Download Data
DateValue
Dec 31, 2025 -1.61
Sep 30, 2025 -2.12
Jun 30, 2025 -2.29
Mar 31, 2025 -2.46
Dec 31, 2024 -3.40
Sep 30, 2024 -2.99
Jun 30, 2024 -3.02
Mar 31, 2024 -3.74
Dec 31, 2023 -10.22
Sep 30, 2023 -3.74
Jun 30, 2023 -5.18
Mar 31, 2023 -5.87
Dec 31, 2022 -6.90
Sep 30, 2022 -4.80
Jun 30, 2022 -8.84
Mar 31, 2022 -5.23
Dec 31, 2021 -6.90
Sep 30, 2021 0.70
Jun 30, 2021 1.68
Mar 31, 2021 -2.54